https://www.selleckchem.com/ALK.html
3kg [-5.0, 0.3]), this difference was not statistically significant. However, the AG showed a significant reduction in the desire for sweet foods (P=0.005). Although this pilot study did not show that repeated tDCS is able to optimize weight loss, it was able to reduce the desire to eat sweet foods. These findings suggest that a protocol with a larger sample size could determine whether tDCS may be an adjunctive treatment of obesity. Although this pilot study did not show that repeated tDCS is able to optimize weight loss, it was able to reduce the